Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Saved in:
| Title: | Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden. |
|---|---|
| Authors: | Mispelbaum R; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Hattenhauer T; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Bauernfeind FG; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Lau JF; Institute of Pathology, University Hospital Bonn (UKB), Bonn, Germany., Brossart P; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Heine A; Department of Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jun 10; Vol. 14, pp. 1406616. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2024.1406616 |
